Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) has a price-to-earnings ratio of N/Ax that is above its average ratio. Additionally, the 36-month beta value for SHPH is 0.40. There are mixed opinions on the stock, with N/A analysts rating it as a “buy,” N/A rating it as “overweight,” N/A rating it as “hold,” and N/A rating it as “sell.”
The average price predicted by analysts for SHPH is N/A, which is N/A N/A the current price. The public float for SHPH is 0.59M and currently, short sellers hold a 4.68% ratio of that float. The average trading volume of SHPH on July 02, 2025 was 245.38K shares.
SHPH) stock’s latest price update
The stock price of Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) has surged by 15.27 when compared to previous closing price of 3.77, Nevertheless, the company has seen a gain of 25.43% in its stock price over the last five trading days. globenewswire.com reported 2025-06-24 that GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before deducting fees to the placement agent and other offering expenses payable by the Company.
SHPH’s Market Performance
Shuttle Pharmaceuticals Holdings Inc (SHPH) has experienced a 25.43% rise in stock performance for the past week, with a -0.69% drop in the past month, and a -55.37% drop in the past quarter. The volatility ratio for the week is 12.46%, and the volatility levels for the past 30 days are at 13.72% for SHPH. The simple moving average for the past 20 days is 8.20% for SHPH’s stock, with a -75.22% simple moving average for the past 200 days.
Analysts’ Opinion of SHPH
Many brokerage firms have already submitted their reports for SHPH stocks, with N/A repeating the rating for SHPH by listing it as a “N/A.” The predicted price for SHPH in the upcoming period, according to N/A is N/A based on the research report published on N/A of the N/A year N/A.
N/A, on the other hand, stated in their research note that they expect to see SHPH reach a price target of N/A. The rating they have provided for SHPH stocks is “N/A” according to the report published on N/A.
N/A gave a rating of “N/A” to SHPH, setting the target price at N/A in the report published on N/A of the N/A year.
SHPH Trading at -15.64% from the 50-Day Moving Average
After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.96% of loss for the given period.
Volatility was left at 13.72%, however, over the last 30 days, the volatility rate increased by 12.46%, as shares surge +0.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.52% lower at present.
During the last 5 trading sessions, SHPH rose by +25.43%, which changed the moving average for the period of 200-days by -87.94% in comparison to the 20-day moving average, which settled at $4.01. In addition, Shuttle Pharmaceuticals Holdings Inc saw -94.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SHPH starting from N/A, who N/A N/A shares at the price of N/A back on N/A. After this action, N/A now owns N/A shares of Shuttle Pharmaceuticals Holdings Inc, valued at N/A using the latest closing price.
N/A, the N/A of Shuttle Pharmaceuticals Holdings Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for SHPH
Current profitability levels for the company are sitting at:
- -1611.44 for the present operating margin
- -0.17 for the gross margin
The net margin for Shuttle Pharmaceuticals Holdings Inc stands at -1820.94. The total capital return value is set at -2.63. Equity return is now at value -346.19, with -208.00 for asset returns.
Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -7.8. The debt to equity ratio resting at 0.34. The interest coverage ratio of the stock is -10.81.
Currently, EBITDA for the company is -7.7 billion with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of 215.17. The receivables turnover for the company is N/Afor trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.78.
Conclusion
In conclusion, Shuttle Pharmaceuticals Holdings Inc (SHPH) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
